Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
Top Cited Papers
Open Access
- 15 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (8) , 2655-2661
- https://doi.org/10.1182/blood-2006-03-011353
Abstract
CD4+CD25+FOXP3+ regulatory T cells (Treg's) play an important role in the maintenance of immune tolerance. The mechanisms controlling the induction aKeywords
This publication has 40 references indexed in Scilit:
- In vivo peripheral expansion of naive CD4+CD25highFoxP3+ regulatory T cells in patients with multiple myelomaBlood, 2006
- Immune regulation in tumor-bearing hostsCurrent Opinion in Immunology, 2006
- Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cellsJournal of Clinical Investigation, 2005
- Combination B7-Fc Fusion Protein Treatment and Treg Cell Depletion TherapyClinical Cancer Research, 2005
- Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patientsThe Journal of Experimental Medicine, 2005
- TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and ParadoxesAnnual Review of Immunology, 2005
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001